Skip to main content
. 2023 Dec 14;11(12):e008067. doi: 10.1136/jitc-2023-008067

Figure 2.

Figure 2

Immune evaluations. (A) Peripheral blood mononuclear cells (PBMC) were obtained from all patients and evaluated for PAP-specific T-cell immunity by fluorescent ELISPOT. A positive immune response (red, pink) was defined as a statistically significant response to the PAP peptide pool compared with media alone and that was at least threefold greater than pretreatment and >1:1 00 000 cells. Black/gray=no significant response, Blank=no data. Red/black=assay performed with fresh cells in real time. Pink/gray=assay performed with cryopreserved cells. Shown are responses for IFNγ release (left) or granzyme B release (right). Sera obtained pretreatment and at weeks 4 and 12 of treatment were evaluated for changes in cytokines and chemokines. Shown are the changes from pretreatment of CXCL9 (B) and CXCL10 (C). Statistical comparisons are by paired t-test, and p<0.05 was considered statistically significant.